Brigitta Vcelar

2.3k total citations
33 papers, 1.6k citations indexed

About

Brigitta Vcelar is a scholar working on Molecular Biology, Molecular Medicine and Virology. According to data from OpenAlex, Brigitta Vcelar has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Molecular Medicine and 10 papers in Virology. Recurrent topics in Brigitta Vcelar's work include Curcumin's Biomedical Applications (11 papers), HIV Research and Treatment (10 papers) and Erythropoietin and Anemia Treatment (5 papers). Brigitta Vcelar is often cited by papers focused on Curcumin's Biomedical Applications (11 papers), HIV Research and Treatment (10 papers) and Erythropoietin and Anemia Treatment (5 papers). Brigitta Vcelar collaborates with scholars based in Austria, United States and Germany. Brigitta Vcelar's co-authors include Hermann Katinger, Gabriela Stiegler, Christine Armbruster, Gordon T. Bolger, Béda Joos, Walter Jäger, Marek Fischer, Huldrych F. Günthard, Leonardo Aceto and Herbert Kuster and has published in prestigious journals such as Nature Medicine, PLoS ONE and Journal of Virology.

In The Last Decade

Brigitta Vcelar

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitta Vcelar Austria 21 888 566 449 363 342 33 1.6k
Subhash Dhawan United States 22 653 0.7× 564 1.0× 741 1.7× 286 0.8× 65 0.2× 56 1.8k
Kiyoko S. Akagawa Japan 26 238 0.3× 1.7k 2.9× 707 1.6× 269 0.7× 36 0.1× 67 2.7k
S. Garforth United States 19 84 0.1× 625 1.1× 635 1.4× 404 1.1× 125 0.4× 44 1.7k
Elisa Nemes South Africa 22 206 0.2× 806 1.4× 402 0.9× 731 2.0× 32 0.1× 58 1.6k
Laura Giuliani Italy 20 236 0.3× 201 0.4× 375 0.8× 102 0.3× 9 0.0× 34 1.2k
Stéphanie Rose France 24 132 0.1× 788 1.4× 439 1.0× 602 1.7× 127 0.4× 45 1.6k
Lu Ding China 25 588 0.7× 466 0.8× 524 1.2× 327 0.9× 26 0.1× 55 1.7k
Makoto Matsukura Japan 22 451 0.5× 226 0.4× 1.1k 2.4× 518 1.4× 41 0.1× 78 2.2k
Javed N. Agrewala India 22 23 0.0× 910 1.6× 530 1.2× 319 0.9× 92 0.3× 48 1.6k

Countries citing papers authored by Brigitta Vcelar

Since Specialization
Citations

This map shows the geographic impact of Brigitta Vcelar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitta Vcelar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitta Vcelar more than expected).

Fields of papers citing papers by Brigitta Vcelar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitta Vcelar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitta Vcelar. The network helps show where Brigitta Vcelar may publish in the future.

Co-authorship network of co-authors of Brigitta Vcelar

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitta Vcelar. A scholar is included among the top collaborators of Brigitta Vcelar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitta Vcelar. Brigitta Vcelar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bolger, Gordon T., Richard D. Bagshaw, Aimin Tan, et al.. (2019). Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells. Anticancer Research. 39(3). 1161–1168. 11 indexed citations
3.
Bolger, Gordon T., Richard Greil, Brigitta Vcelar, et al.. (2018). Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. Cancer Chemotherapy and Pharmacology. 83(2). 265–275. 25 indexed citations
4.
Bolger, Gordon T., Aimin Tan, Richard Greil, et al.. (2018). Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia. Anticancer Research. 38(1). 121–130. 7 indexed citations
5.
Bolger, Gordon T., et al.. (2017). Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance. Anticancer Research. 37(7). 3483–3492. 15 indexed citations
6.
Simon, Florian, Philipp Erhart, Brigitta Vcelar, et al.. (2015). Erythropoietin preconditioning improves clinical and histologic outcome in an acute spinal cord ischemia and reperfusion rabbit model. Journal of Vascular Surgery. 64(6). 1797–1804. 24 indexed citations
7.
Wolzt, Michael, et al.. (2015). Comparison of pharmacokinetic and safety profiles between Bemfola® and Gonal-f® after subcutaneous application. European Journal of Drug Metabolism and Pharmacokinetics. 41(3). 259–265. 12 indexed citations
8.
Wiggins, Rebecca, Sarah C Woodhall, Martin Bland, et al.. (2014). MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide. PLoS ONE. 9(12). e116153–e116153. 27 indexed citations
9.
Storka, Angela, Brigitta Vcelar, Ghazaleh Gouya, et al.. (2013). Effect of liposomal curcumin on red blood cells in vitro.. PubMed. 33(9). 3629–34. 12 indexed citations
10.
Tayra, Judith Thomas, Masahiro Kameda, Takao Yasuhara, et al.. (2013). The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson’s disease. Brain Research. 1502. 55–70. 28 indexed citations
11.
Schaller, Georg, Peter Dittrich, Ghazaleh Gouya, et al.. (2012). Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase. International Journal of Clinical Pharmacology and Therapeutics. 50(6). 413–417. 4 indexed citations
12.
Simon, Florian, Angelika Scheuerle, Michael Gröger, et al.. (2011). Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Medicine. 37(9). 1525–1533. 30 indexed citations
13.
Heinisch, Birgit, Brigitta Vcelar, Stylianos Kapiotis, et al.. (2011). The effect of erythropoietin on platelet and endothelial activation markers: A prospective trial in healthy volunteers. Platelets. 23(5). 352–358. 13 indexed citations
14.
Vcelar, Brigitta, Gabriela Stiegler, Hermann M. Wolf, et al.. (2007). Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data. AIDS. 21(16). 2161–2170. 42 indexed citations
15.
Trkola, Alexandra, Herbert Kuster, Peter Rusert, et al.. (2005). Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nature Medicine. 11(6). 615–622. 388 indexed citations
16.
17.
Armbruster, Christine, Gabriela Stiegler, Brigitta Vcelar, et al.. (2004). Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. Journal of Antimicrobial Chemotherapy. 54(5). 915–920. 83 indexed citations
18.
Armbruster, Christine, Gabriela Stiegler, Brigitta Vcelar, et al.. (2002). A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1. AIDS. 16(2). 227–233. 108 indexed citations
19.
Stiegler, Gabriela, Christine Armbruster, Brigitta Vcelar, et al.. (2002). Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans. AIDS. 16(15). 2019–2025. 85 indexed citations
20.
Riedl, Claus, et al.. (2001). Pilot Study on Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie’s Disease. European Urology. 40(3). 343–349. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subhash Dhawan Breakdown of academic impact, for papers by Kiyoko S. Akagawa Breakdown of academic impact, for papers by S. Garforth Breakdown of academic impact, for papers by Elisa Nemes Breakdown of academic impact, for papers by Laura Giuliani Breakdown of academic impact, for papers by Stéphanie Rose Breakdown of academic impact, for papers by Lu Ding Breakdown of academic impact, for papers by Makoto Matsukura Breakdown of academic impact, for papers by Javed N. Agrewala
Rankless by CCL
2026